ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...7891011121314151617...129130»
  • ||||||||||  ivermectin oral / Generic mfg., albendazole / Generic mfg.
    Pet Dogs, Episodic Asthma-like Symptoms, and Eosinophilia: A Conundrum of Echinococcus, Strongyloidiasis, and Mycobacterium Gordonae (Walter E. Washington Convention Center, Area C, Hall C (Lower Level)) -  Mar 25, 2023 - Abstract #ATS2023ATS_8450;    
    He was prescribed Albendazole...Symptomatic pulmonary infection by M. gordonae in the immunocompetent is uncommon in the absence of pre-existing lung disease. Although M. gordonae is the least pathogenic mycobacterium and its isolation typically regarded as a contaminant, our patient had a RUL cavity with pulmonary symptoms.
  • ||||||||||  ivermectin oral / Generic mfg., ivermectin topical / Generic mfg.
    Persistent Hypereosinophilia: An Unveil Case of Chronic Lymphocytic Leukemia (Walter E. Washington Convention Center, Area D, Hall C (Lower Level)) -  Mar 25, 2023 - Abstract #ATS2023ATS_4820;    
    Unusual association suggests that peripheral blood eosinophilia could potentially be used as a marker for early identification of CLL. A prompt diagnosis will help to start early treatment and identify those with worst prognosis.
  • ||||||||||  ivermectin oral / Generic mfg.
    Strongyloides Stercoralis Infection Mimicking Metastatic Lung Cancer Detected By Endobronchial Ultrasound - Transbronchial Needle Aspiration (Walter E. Washington Convention Center, Room 140 A-B (Street Level)) -  Mar 25, 2023 - Abstract #ATS2023ATS_3240;    
    Case Presentation: A 53-year-old woman with a history of stage IV lung adenocarcinoma stable on osimertinib presented with new right paratracheal adenopathy on surveillance imaging...Additionally, sputum gram stain, bronchoalveolar lavage, and pleural fluid can be used in the diagnosis of Strongyloides lung infections, but discovery by EBUS-TNBA of intrathoracic lymph nodes has not been reported to our knowledge. EBUS-TBNA is a valuable tool for the diagnosis of intrathoracic adenopathy and Strongyloides should be considered in patients with intrathoracic adenopathy and travel to endemic areas, even in the paucity of respiratory or GI symptoms.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19. (Pubmed Central) -  Mar 24, 2023   
    EBUS-TBNA is a valuable tool for the diagnosis of intrathoracic adenopathy and Strongyloides should be considered in patients with intrathoracic adenopathy and travel to endemic areas, even in the paucity of respiratory or GI symptoms. No abstract available
  • ||||||||||  moxidectin / Generic mfg., ivermectin oral / Generic mfg.
    Review, Journal:  Ivermectin and moxidectin against soil-transmitted helminth infections. (Pubmed Central) -  Mar 20, 2023   
    This review provides insights on recent studies evaluating the efficacy of ivermectin and moxidectin as single or coadministered therapy against human soil-transmitted helminthiases (including Strongyloides stercoralis infections) and on pharmacokinetic/pharmacodynamic parameters measured in treated populations. Furthermore, we discuss current gaps for research, highlight advantages - but also existing challenges - for uptake of ivermectin and/or moxidectin treatment schemes into routine STH control in endemic countries.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Electrochemical Characterisation and Confirmation of Antioxidative Properties of Ivermectin in Biological Medium. (Pubmed Central) -  Mar 16, 2023   
    The redox behaviour of IVM in a biological matrix (human serum pool) showed a pronounced antioxidant potential similar to that of Trolox during short incubation, whereas a prolonged stay among biomolecules and in the presence of an exogenous pro-oxidant (tert-butyl hydroperoxide, TBH) resulted in a loss of its antioxidant effect. The antioxidant potential of IVM was confirmed by voltametric methodology which is proposed for the first time.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? (Pubmed Central) -  Mar 15, 2023   
    As a result, it can be suggested that ivermectin has positive effects on the immune response and that its oxidative actions are of therapeutic value and do not harm the systemic oxidative status, as in untreated goats. This editorial examines what has caused the evidence around ivermectin to be so controversial, provides a brief analysis of recently published evidence, and highlights why it is important to learn lessons from ivermectin for future re-purposed drugs.
  • ||||||||||  ivermectin oral / Generic mfg.
    Review, Journal:  Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy? (Pubmed Central) -  Mar 14, 2023   
    Fourth, the only robust clinical evidence of anti-seizure effects stems from the treatment of patients with onchocerciasis in which the reduction of seizures is due to a reduction in microfilariae densities but not a direct anti-seizure effect of ivermectin. We hope that this critical analysis of available data will avert that the unjustified hype associated with the recent use of ivermectin to control COVID-19 recurs also in neurological diseases such as epilepsy.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Ivermectin and the Emergence of Long COVID. (Pubmed Central) -  Mar 13, 2023   
    We hope that this critical analysis of available data will avert that the unjustified hype associated with the recent use of ivermectin to control COVID-19 recurs also in neurological diseases such as epilepsy. No abstract available
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Environmental risk caused by drug waste in the city of Rio de Janeiro, Brazil, during the SARS-Cov19 pandemic. (Pubmed Central) -  Mar 13, 2023   
    While the PECest of diazepam (DIA) increased over these 3 years, ethinylestradiol (EE2) decreased possibly due to the prioritization of PHC in the treatment of COVID-19...The consumption pattern of these drugs did not reflect their environmental risk because the most consumed ones have low toxicity. It is worth noting that some data may be underestimated due to the incentive given during the pandemic to the consumption of certain groups of drugs.
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion date, Trial initiation date, Trial primary completion date:  Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) (clinicaltrials.gov) -  Mar 13, 2023   
    P4,  N=100, Not yet recruiting, 
    It is worth noting that some data may be underestimated due to the incentive given during the pandemic to the consumption of certain groups of drugs. Trial completion date: Mar 2024 --> Jun 2024 | Initiation date: Jan 2023 --> Apr 2023 | Trial primary completion date: Sep 2023 --> Dec 2023